Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vanda Pharmaceuticals (VNDA) EPS (Basic): 2009-2024

Historic EPS (Basic) for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Dec 2024 value amounting to -$0.33.

  • Vanda Pharmaceuticals' EPS (Basic) fell 322.22% to -$0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.43, marking a year-over-year decrease of 393.10%. This contributed to the annual value of -$0.33 for FY2024, which is 925.00% down from last year.
  • Vanda Pharmaceuticals' EPS (Basic) amounted to -$0.33 in FY2024, which was down 925.00% from $0.04 recorded in FY2023.
  • In the past 5 years, Vanda Pharmaceuticals' EPS (Basic) registered a high of $0.60 during FY2021, and its lowest value of -$0.33 during FY2024.
  • Over the past 3 years, Vanda Pharmaceuticals' median EPS (Basic) value was $0.04 (recorded in 2023), while the average stood at -$0.06.
  • Per our database at Business Quant, Vanda Pharmaceuticals' EPS (Basic) soared by 39.53% in 2021 and then slumped by 925.00% in 2024.
  • Over the past 5 years, Vanda Pharmaceuticals' EPS (Basic) (Yearly) stood at $0.43 in 2020, then surged by 39.53% to $0.60 in 2021, then plummeted by 81.67% to $0.11 in 2022, then plummeted by 63.64% to $0.04 in 2023, then tumbled by 925.00% to -$0.33 in 2024.